headerbmd_series
Whitepapers

Molecular Diagnostics in the Clinical Laboratory

March 28, 2024
Learn how clinical laboratories can use a combination of technologies to create a comprehensive and robust molecular diagnostic framework that aligns with the evolving demands...
Photo 113739245 © motortion | Dreamstime.com
Genomics

International Pathogen Surveillance Network launches catalytic grant fund for pathogen genomics

Feb. 26, 2024
More details on the IPSN catalytic grant fund can be found online.
Photo 305592659 | Ai © Ruslan Batiuk | Dreamstime.com
Photo 23320779 © Dlumen Dlumen | Dreamstime.com
Molecular

FDA approves first cellular therapy to treat patients with unresectable or metastatic melanoma

Feb. 19, 2024
The FDA granted the approval of Amtagvi to Iovance Biotherapeutics Inc.
Photo 53478255 © Hootie2710 | Dreamstime.com
Molecular

Multiply Labs and Thermo Fisher Scientific expand partnership to automate cell expansion and separation in cell therapy manufacturing

Feb. 13, 2024
Automating Thermo Fisher’s GMP-ready instruments using Multiply Labs’ robotic technology helps reduce costs and accelerates timelines.
Photo 303440018 © Ruslan Batiuk | Dreamstime.com
Molecular

Destroying tumor cells with calcium

Feb. 8, 2024
Activating calcium channels leads to a deadly influx of calcium ions into tumor cells.
Photo 219298288 | Acute Lymphoblastic Leukemia © Jarun011 | Dreamstime.com
DNA/RNA

RNA sequencing analysis may hold the key to more accurate diagnosis and targeted treatment of pediatric B-acute lymphoblastic leukemia

Feb. 7, 2024
Pilot study by Children’s Hospital Los Angeles and City of Hope proposes a promising global, clinically applicable genomic assay for the diagnosis and treatment of this heterogeneous...
Photo 714165 © Starfotograf | Dreamstime.com
Molecular

Integrated DNA Technologies and Element Biosciences accelerate next generation sequencing workflows for Element’s AVITI System

Feb. 6, 2024
Partnership includes launch of new IDT xGen NGS products designed exclusively for Element’s AVITI System.
Photo 126247162 © motortion | Dreamstime.com
Photo 136676134 © Golfxx | Dreamstime.com
Molecular

Infusion of bone marrow mononuclear cells results in decreased intensive care needs and white matter preservation for children with severe traumatic brain injury

Jan. 25, 2024
The researchers are now in the process of developing the design and approach of a pivotal Phase III clinical trial.